Archives: Speakers

Dr Domenico Merante completed his degree in medicine in 1988 at the age of 25 and in 1993 became specialist of endocrinology, diabetes and metabolic diseases, both degrees obtained at the University of Pisa/Italy. Dr Merante is currently Clinical Research Lead TA Orphan/ Nephrology at CSL Vifor in Glattbrugg, Switzerland. He previously worked at Sosei Heptares in 2018-2019 as VP of Clinical Development and at Shionogi as VP and Head of Clinical Science in 2017 and 2018. Between 2007 and 2016 he covered the role of Senior Director of Clinical Development at Daiichi Sankyo Development Ltd, UK heading the European Frontiers/Opportunity Department. Dr Merante had previously worked at GSK Italy, Eli Lilly Italy, Novo Nordisk UK and Laboratori Guidotti Italy in several clinical positions. So far Dr Merante has spent 28 years in drug clinical development working in Italy, UK, US and Switzerland in multiple therapeutic areas. These include diabetes and complications (i.e. macular edema and neuropathic pain), fibromyalgia, endocrinology area (i.e. growth hormone deficiencies, Cushing syndrome), severe hypertension, infectious diseases, hematology and nephrology/orphan and rare diseases. Dr Merante has to date 119 publications amongst full papers, abstracts as either main author or co-author and oral presentations made during scientific or industry-based conferences.

Dr. Yunis is a scientist with multidisciplinary training and experience in the mechanism of diseases. Reem enjoys working in startups bringing forward long-term vision and strategies. At Medable, she works cross-functionally with engineering, product development, regulatory, AI/ML, and data science to develop first-in-class DCT solutions. She leads the scientific development of digital clinical measures and the modernization of clinical development models under the banner ‘Technology As Methodology’. Prior to Medable, Reem worked in the clinical space in both the industry and academia settings after making a transition from basic science research. Reem holds a PhD in genetics from the Hebrew University of Jerusalem.

Dr. Karl McEvoy has over a decade of industry experience in both the vendor and sponsor sides. His clinical trial experience spans from set-up to delivery across all phases in a wide variety of disease and therapeutic areas. Karl has collaborated with the world’s top 20 pharmaceutical companies and has extensive experience in patient-centered outcomes research, eCOA strategy, and drug development.

Francis is an expert in clinical system regulatory compliance with over 20 years pharma experience spanning R&D, manufacturing and clinical research.  Francis has lead supplier oversight responsibilities for sponsors, CROs and clinical system vendors.

Laura is a Clinical Research Professional. She started in Novo Nordisk in 2013 as CRA and since 2020 she’s exploring and defining Clinical Innovation as Clinical Innovation Manager.

In her current position, she’s leading the Innovation Strategy in her department – Clinical Operations in France, Portugal and Spain and additionally, driving the change and bringing innovation in Region Europe.

Her superpowers: communication, innovation and collaboration.